NCT03680781View on ClinicalTrials.gov

Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 13, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Treatment Resistant Depression
Interventions
DEVICE

Intermittent theta-burst stimulation (iTBS)

"Participants will receive iTBS to the left DLPFC or bilateral DLPFC, to the right and left DLPFC. The DLPFC will be targeted utilizing either Localite's neuronavigation system or Nexstim's eField neuronavigation system. Stimulation intensity will be standardized at 90% of RMT and adjusted to the skull to cortical surface distance (see Nahas 2004).~Stimulation will be delivered to the L-DLPFC or bilateral DLPFC using either a MagVenture MagPro X100 or a Nexstim TMS device."

Trial Locations (1)

94305

Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT03680781 - Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study | Biotech Hunter | Biotech Hunter